JC

Jorge Conde

General Partner at Andreessen Horowitz

Menlo Park, California

Overview 

Jorge Conde is a General Partner at Andreessen Horowitz, overseeing investments in various sectors including Biotech, FinTech, and Consumer Internet. With a strong background in lifesciences and biotechnology, he has successfully invested in and served on the boards of companies like Tome Biosciences and Dyno Therapeutics. Conde holds an MBA from Harvard Business School and has made significant contributions to the growth and success of startups through his strategic investments and board memberships, demonstrating expertise in biotechnology and venture capital within the San Francisco Bay Area.

Work Experience 

  • General Partner

    2017 - Current

    Investing at the cross section of biology, computer science and engineering.

Andreessen Horowitz is a stage-agnostic venture capital firm with assets under management across multiple funds.

  • Board Member

    2022

  • Board Member

    2022

  • Board Member

    2022

Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest, most effective targets.

Raised $57,000,000.00 from Gaingels, Artis Ventures (AV), Cancer Research Institute, Alexandria Venture Investments, Andreessen Horowitz, AME Cloud Ventures, Catalio Capital Management, Wing Venture Capital and 8VC.

  • Board Member

    2021

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

Raised $213,000,000.00 from Alexandria Venture Investments, Polaris Partners, Fujifilm, Andreessen Horowitz, ARCH Venture Partners, Bruker, Google Ventures and Longwood Fund.

  • Board Member

    2021

Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.

Raised $109,000,000.00 from Polaris Partners, KdT Ventures, Sahsen Ventures, Obvious Ventures, Andreessen Horowitz, CRV, Lux Capital, Casdin Capital and Google Ventures.

  • Board Member

    2020

Komodo Health is an IT firm that specializes in data engineering, life sciences, artificial intelligence, and machine intelligence services.

Raised $514,000,000.00 from Dragoneer Investment Group and Coatue.

  • Board Member

    2019

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Raised $115,000,000.00 from What If Ventures, Allen & Company, Bristol-Myers Squibb, Andreessen Horowitz, Fifty Years, Catalio Capital Management, Bioverge and Flucas Ventures.

  • Board Member

    2019

  • Board Member

    2018

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Raised $190,000,000.00 from The Kraft Group, Enavate Sciences, Andreessen Horowitz, Gaingels, Polaris Partners, Northpond Ventures and 5AM Ventures.

Articles About Jorge

Relevant Websites